| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 04/08/2003 | US6544960 Chemical compounds |
| 04/08/2003 | US6544957 Histone acetylase inhibitor |
| 04/08/2003 | US6544955 Method of sensitizing tumor cells with adenovirus E1A |
| 04/08/2003 | US6544954 Demonstrate high stability after sterilization by autoclaving and storage at 80 degrees C. for at least two weeks |
| 04/08/2003 | US6544951 Antiinflammatory agents; autoimmune diseases, nervous system degradation |
| 04/08/2003 | US6544927 Use of α2-adrenergic receptor agonists and adrenergic inhibitors in reducing defoliation |
| 04/08/2003 | US6544784 Multiple-tumor aberrant growth genes |
| 04/08/2003 | US6544759 Polynucleotides encoding a novel growth factor which acts through ErbB-4 kinase receptor tyrosine |
| 04/08/2003 | US6544740 Measuring protease; calibration; insertion of enbryos |
| 04/08/2003 | US6544566 For prophylaxis and minimizing development of atherosclerosis |
| 04/08/2003 | US6544565 Administering to the host a pharmaceutically effective amount of 10(14)-Aromadendren-4-ol, 6, 10(14)- Guaiadien-4-ol, Valerenal, Valerenol, Valerenic acid, Acetoxyvalerenic acid, Hydroxyvalerenic acid or combinations thereof. |
| 04/08/2003 | US6544563 Synergistic mixture of arginine and nitric oxide synthase |
| 04/08/2003 | US6544562 For therapy of acne vulgaris, white heads, black heads and comedones |
| 04/08/2003 | US6544559 Such as 3-(2-(4-(6-fluoro-1,2-benzisoxazol-3-yl)-1-piperidinyl)ethyl)-6,7,8,9 -tetrahydro-2-methyl-4H-pyrido (1,2-a)pyrimidin-4-one for sustained-release via biodegradation; for treatment of mental illness |
| 04/08/2003 | US6544558 Granulates compacted together into a tablet form together with an extra-granular lubricant; especially amoxycillin plus clavulanic acid, and crosslinked polyvinylpyrrolidone or sodium starch glycolate intra-granular disintegrant |
| 04/08/2003 | US6544557 Effervescent tablet compositions |
| 04/08/2003 | US6544556 Prevents gastrointestinal side effects |
| 04/08/2003 | US6544555 Dosage forms; variations in rrelease profile |
| 04/08/2003 | US6544551 Solid pharmaceutical compositions containing hexedecylphosphocholine (miltefosine) for oral administration in the treatment of leishmaniasis |
| 04/08/2003 | US6544550 Medicaments for gastrointestinal disorders |
| 04/08/2003 | US6544549 Multilamellar coalescence vesicles (MLCV) containing biologically active compounds |
| 04/08/2003 | US6544547 Nutritional composition containing methionine |
| 04/08/2003 | US6544545 Providing needle-less device comprising a barrel member and a plunger, contacting first end of the barrel member to the patient's skin; depressing the plunger, thereby forcing medicament through the skin, to thereby administer medicament |
| 04/08/2003 | US6544544 Compound which disrupts microtubule function and polymeric carrier, with proviso that polymeric carrier is not a capsule |
| 04/08/2003 | US6544542 For the administration of a drug which is sparingly soluble in water |
| 04/08/2003 | US6544541 Devices and compounds for treating arterial restenosis |
| 04/08/2003 | US6544533 10-hydroxy-2-decenoic acid compounds for promoting desquamation/epidermal renewal of the skin and/or combating skin aging |
| 04/08/2003 | US6544525 Compositions and methods for reducing or controlling blood cholesterol, lipoproteins, triglycerides and atherosclerosis |
| 04/08/2003 | US6544518 Vaccines |
| 04/08/2003 | US6544502 Skin treatment with a water soluble antibiotic dissolved in an electrolyzed water |
| 04/08/2003 | US6544499 Polysiloxane or silicone resin, a linker, and a molecular hook for treating amino acid based substrates; hair care |
| 04/08/2003 | US6544497 Modulated release particles for aerosol delivery |
| 04/08/2003 | US6544193 Noninvasive measurement of chemical substances |
| 04/08/2003 | US6544166 Treatment of human infertility |
| 04/08/2003 | CA2333701C .alpha.-hydroxy fatty acid derivatives and external compositions containing the same |
| 04/08/2003 | CA2332397C Method of making antiperspirant powders |
| 04/08/2003 | CA2294305C Antisense oligonucleotide sequences as inhibitors of microorganisms |
| 04/08/2003 | CA2275323C Asymmetric synthesis of benzoxazinones |
| 04/08/2003 | CA2254152C New metalloprotease inhibitors, their preparation process and the pharmaceutical compositions which use them |
| 04/08/2003 | CA2252898C Mesylate dihydrate salts of 5-(2-(4-(1,2-benzisothiazol-3-yl)-1-piperazinyl)-ethyl)-6-chloro-1,3-dihydro-2(1h)-indol-2-one(=ziprasidone), its preparation and its use as dopamine d2 antagonist |
| 04/08/2003 | CA2232583C Lipoic acid in topical compositions |
| 04/08/2003 | CA2224983C Triazole antifungal agents |
| 04/08/2003 | CA2172245C Method of treating gram-negative bacterial infection by administration of bactericidal/permeability-increasing (bpi) protein |
| 04/08/2003 | CA2123548C Piperazine derivatives |
| 04/08/2003 | CA2112165C Bicyclic amine derivatives |
| 04/08/2003 | CA2109830C Lhrh antagonists and intermediate products |
| 04/08/2003 | CA2101423C Benzamides |
| 04/08/2003 | CA2097824C Functionalized vinyl azoles and their use |
| 04/08/2003 | CA2096833C Method for preparing taxane derivatives, novel derivatives thereby obtained and pharmaceutical compositions containing same |
| 04/08/2003 | CA2086756C Penciclovir and famciclovir and related guanine derivatives for the treatment of the hiv-1 infections |
| 04/08/2003 | CA2084431C 17-spirofuran-3'-ylidene steroids |
| 04/08/2003 | CA2071623C Cyclodextrin composition |
| 04/08/2003 | CA2065849C Vitamin d analogues |
| 04/08/2003 | CA2062271C Derivatives of substituted imidazol-2-one and process for their preparation |
| 04/08/2003 | CA2061907C Treatment of ocular hypertension with a synergistic combination |
| 04/08/2003 | CA2053216C Saturated hydroxyalkylquinoline acids as leukotriene antagonists |
| 04/08/2003 | CA2049212C 6-substituted-tetrahydrobenz ¬cd| indoles |
| 04/08/2003 | CA2048243C 4-amino- 4,6-steroids and their use as 5-.alpha.-reductase inhibitors |
| 04/08/2003 | CA2033190C N-phenylalkyl substituted alpha-amino carboxamide derivatives and process for their preparation |
| 04/08/2003 | CA2023810C Pharmaceutical composition |
| 04/08/2003 | CA2001903C 1,2,4-benzotriazine oxides as radiosensitizers and selective cytotoxic agents |
| 04/07/2003 | WO2002038152A1 Combination of amines and vanadium (iv)/(v) compounds for the treatment and/or prevention of diabetes mellitus |
| 04/07/2003 | WO2002032866A1 (4-acylaminopiperidin-1-yl) acetamides as neurokinin antagonists |
| 04/07/2003 | CA2425192A1 Combination of amines and vanadium (iv)/(v) compounds for the treatment and/or prevention of diabetes mellitus |
| 04/04/2003 | WO2002030940A2 Low molecular serine protease inhibitors comprising polyhydroxy-alkyl and polyhydroxy-cycloalkyl radicals |
| 04/04/2003 | WO2002030390A2 Method for producing powdery formulations |
| 04/04/2003 | CA2424926A1 Low molecular serine protease inhibitors comprising polyhydroxy-alkyl and polyhydroxy-cycloalkyl radicals |
| 04/03/2003 | WO2003028001A2 Method and pharmaceutical composition for inducing cancer cell-specific apoptosis by combination with tnf family proteins and flavopiridol |
| 04/03/2003 | WO2003027927A1 Dna providing system |
| 04/03/2003 | WO2003027632A2 Use of isogenic human cancer cells for high-throughput screening and drug discovery |
| 04/03/2003 | WO2003027322A2 Hepatocellular carcinoma-related genes and polypeptides, and method for detecting hepatocellular carcinomas |
| 04/03/2003 | WO2003027319A1 Aptamers containing sequences of nucleic acids or nucleic acid analogues bound homologously, or in novel complexes |
| 04/03/2003 | WO2003027317A2 Use of active substances for the prophylaxis and/or treatment of diseases caused by cell growth disturbances and test system for discovery of said active substances |
| 04/03/2003 | WO2003027316A2 Methods of using 33751, a human potassium channel family member |
| 04/03/2003 | WO2003027275A1 Inhibitors of glycogen synthase kinase-3 (gsk-3) for treating glaucoma |
| 04/03/2003 | WO2003027266A2 Whitefly ecdysone receptor nucleic acids, polypeptides, and uses thereof |
| 04/03/2003 | WO2003027254A2 15625 receptor, a novel g-protein coupled receptor |
| 04/03/2003 | WO2003027244A2 Antisense oligonucleotides and methods to induce tumor cell death |
| 04/03/2003 | WO2003027234A2 Small organic molecule regulators of cell proliferation |
| 04/03/2003 | WO2003027169A1 Material consisting of at least a biodegradable polymer and cyclodextrins |
| 04/03/2003 | WO2003027143A2 Gene and protein relating to hepatocellular carcinoma |
| 04/03/2003 | WO2003027128A1 Chemical compounds |
| 04/03/2003 | WO2003027118A1 Pharmaceutically acceptable salts of 20(s)-camptothecins |
| 04/03/2003 | WO2003027116A2 Substituted 2-pyridinyl-6,7,8,9-tetrahydropyrimido[1,2-a]pyrimidin-4-one and 7-pyridinyl-2,3-dihydroimidazo[1,2-a]pyrimidin-5(1h)one derivatives |
| 04/03/2003 | WO2003027115A1 Substituted 2-pyrimidinyl-6,7,8,9-tetrahydropyrimido[1,2-a]pyrimidin-4-one and 7-pyrimidinyl-2,3-dihydroimidazo[1,2-a]pyrimidin-5(1h)one derivatives for neurodegenerative disorders |
| 04/03/2003 | WO2003027114A1 Preparation and use of 1,5,6,7-tetrahydropyrrolo[3,2-c]pyridine derivatives for treatment of obesity |
| 04/03/2003 | WO2003027113A1 1,6-naphthyridine derivatives as antidiabetics |
| 04/03/2003 | WO2003027112A1 1, 8-naphthyridine derivatives as antidiabetics |
| 04/03/2003 | WO2003027111A1 Chemical compounds |
| 04/03/2003 | WO2003027107A1 Substituted 3-pyridyl oxazoles as c17,20 lyase inhibitors |
| 04/03/2003 | WO2003027105A1 Substituted 3-pyridyl thiophenes as c17,20 lyase inhibitors |
| 04/03/2003 | WO2003027102A1 3-(arylamino)methylene-1, 3-dihydro-2h-indol-2-ones as kinase inhibitors |
| 04/03/2003 | WO2003027101A1 Substituted 3-pyridyl pyrroles and 3-pyridyl pyrazoles as c17,20 lyase inhibitors |
| 04/03/2003 | WO2003027100A1 Substituted 3-pyridyl pyrimidines as c17,20 lyase inhibitors |
| 04/03/2003 | WO2003027097A1 Substituted alkylaminopyridazinone derivatives, process for the preparation thereof and pharmaceutical composition containing the same |
| 04/03/2003 | WO2003027096A1 Substituted 3-pyridyl imidazoles as c17,20 lyase inhibitors |
| 04/03/2003 | WO2003027095A1 Substituted 3-pyridyl tetrazoles as steroid c17,20 lyase inhibitors |
| 04/03/2003 | WO2003027094A2 Substituted 3-pyridyl indoles and indazoles as c17,20 lyase inhibitors |
| 04/03/2003 | WO2003027093A1 Chemical compounds |
| 04/03/2003 | WO2003027090A2 Bicyclic heterocycles as rxr ligands |